Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Yescarta Market Report 2025

Yescarta Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Large B-Cell Lymphoma, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia, Follicular Lymphoma), By Distribution Channel (Hospitals, Specialty Clinics, Online Pharmacies), By End User (Adult, Geriatric)

Yescarta Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Yescarta Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Yescarta Market Definition

Yescarta (axicabtagene ciloleucel) is a genetically engineered autologous T-cell therapy used for the treatment of certain types of hematologic cancers, specifically relapsed or refractory large B-cell lymphoma and primary mediastinal B-cell lymphoma in adults. It involves modifying a patient’s own T cells to express a chimeric antigen receptor (CAR) that targets CD19 on cancerous B cells.

The main indication for yescarta are large b-cell lymphoma, mantle cell lymphoma, acute lymphoblastic leukemia, Follicular Lymphoma. Large B-cell lymphoma (LBCL) is an aggressive type of non-Hodgkin lymphoma, a cancer that originates in the lymphatic system. These are distributed through various distribution channels such as hospitals, specialty clinics, online pharmacies and are used by various end users such as adult, geriatric.

Yescarta Market Segmentation

The yescarta market covered in this report is segmented –

1) By Indication: Large B-Cell Lymphoma; Mantle Cell Lymphoma; Acute Lymphoblastic Leukemia; Follicular Lymphoma

2) By Distribution Channel: Hospitals; Specialty Clinics; Online Pharmacies

3) By End User: Adult; Geriatric

Yescarta Market Size and growth rate 2025 to 2029: Graph

Yescarta Market Size 2025 And Growth Rate

The yescarta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing adoption of immuno-oncology treatments, breakthrough approvals from regulatory agencies, growing prevalence of blood cancers, advancements in gene therapy technologies, increasing healthcare investments in oncology.

Yescarta Market Growth Forecast

The yescarta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast expansion into new cancer indications, advancements in manufacturing technologies, increasing healthcare reimbursement for gene therapies, growing patient awareness and demand, strategic partnerships in oncology research. Major trends include the expansion of car T-cell therapies to solid tumors, the development of next-generation car T-cell therapies, increasing focus on personalized cancer treatments, advancements in automation for car T-cell production, growing adoption of combination therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

Yescarta Market Driver: Impact Of Rising Leukemia Incidence On The Market Growth

The increasing incidence of leukemia is expected to propel the growth of the yescarta market going forward. Leukemia is a type of cancer that affects the blood and bone marrow, leading to the abnormal production of white blood cells. The increasing incidence of leukemia may be attributed to factors such as environmental exposures, genetic mutations, lifestyle changes, and improved detection methods. Yescarta, an advanced CAR T-cell therapy, revolutionizes leukemia treatment by reprogramming a patient’s own immune cells to target and destroy cancerous cells, offering renewed hope for improved outcomes in battling the disease. For instance, in 2024, according to the American Cancer Society, a US-based non-profit cancer advocacy organization, the number of leukemia cases increased to 62,770, reflecting an increase from 59,610 recorded in 2023. Therefore, the increasing incidence of leukemia drives the yescarta market.

Global Yescarta Market Major Players

Major companies operating in the yescarta market are Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.)

Global Yescarta Market Trend: Advancing Oncology With Key Trends And Innovations In The Market

The key trend in the yescarta market is focusing on developing advanced biologics such as CAR T-cell therapy to enhance treatment efficacy, expand therapeutic applications, and improve patient outcomes in oncology. CAR T-cell therapy works by modifying a patient’s T cells to target and destroy cancer cells, offering personalized treatment with the potential for long-term remission and fewer side effects. For instance, in April 2022, Kite Pharma, a US-based company that manufactures biologics, announced that the U.S. Food and Drug Administration (FDA) approved Yescarta (axicabtagene ciloleucel) for the initial treatment of relapsed or refractory large B-cell lymphoma (LBCL). This marks the first CAR T-cell therapy approved for this indication, highlighting the ongoing progress in cancer treatment through innovative therapies that leverage the body's immune system to fight cancer more effectively.

Yescarta Market Merger And Acquisition: Strengthening Global Collaboration With Kite Pharma And Daiichi Sankyo Expand Yescarta's Reach In Japan

In December 2022, Kite Pharma Inc., a US-based biotechnology company,  announced a strategic enhancement to its partnership with Daiichi Sankyo Ltd. regarding Yescarta (axicabtagene ciloleucel), an innovative CAR T-cell therapy. Initially established in 2017, this collaboration focuses on improving access to this groundbreaking treatment for patients in Japan with relapsed or refractory large B-cell lymphoma. Daiichi Sankyo Ltd. is a Japan-based company that develops pharmaceuticals.

Regional Analysis For The Global Yescarta Market

North America was the largest region in the yescarta market in 2024. The regions covered in the yescarta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yescarta market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Yescarta Market?

The yescarta market consists of sales of cell-based therapies and intravenous (IV) infusion. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. 

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Yescarta Industry?

The yescarta market research report is one of a series of new reports from The Business Research Company that provides yescarta market statistics, including yescarta industry global market size, regional shares, competitors with a yescarta market share, detailed yescarta market segments, market trends, and opportunities, and any further data you may need to thrive in the yescarta industry. This yescarta market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Yescarta Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The yescarta market covered in this report is segmented –
1) By Indication: Large B-Cell Lymphoma; Mantle Cell Lymphoma; Acute Lymphoblastic Leukemia; Follicular Lymphoma
2) By Distribution Channel: Hospitals; Specialty Clinics; Online Pharmacies
3) By End User: Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.)
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Yescarta Market Characteristics

    3. Yescarta Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Yescarta Market Trends And Strategies

    5. Yescarta Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Yescarta Growth Analysis And Strategic Analysis Framework

    6.1. Global Yescarta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Yescarta Market Growth Rate Analysis

    6.4. Global Yescarta Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Yescarta Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Yescarta Total Addressable Market (TAM)

    7. Global Yescarta Pricing Analysis & Forecasts

    8. Yescarta Market Segmentation

    8.1. Global Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Large B-Cell Lymphoma

    Mantle Cell Lymphoma

    Acute Lymphoblastic Leukemia

    Follicular Lymphoma

    8.2. Global Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Specialty Clinics

    Online Pharmacies

    8.3. Global Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Adult

    Geriatric

    9. Global Yescarta Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Yescarta Market Regional And Country Analysis

    10.1. Global Yescarta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Yescarta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Yescarta Market

    11.1. Asia-Pacific Yescarta Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Yescarta Market

    12.1. China Yescarta Market Overview

    12.2. China Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Yescarta Market

    13.1. India Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Yescarta Market

    14.1. Japan Yescarta Market Overview

    14.2. Japan Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Yescarta Market

    15.1. Australia Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Yescarta Market

    16.1. South Korea Yescarta Market Overview

    16.2. South Korea Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Yescarta Market

    17.1. Western Europe Yescarta Market Overview

    17.2. Western Europe Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Yescarta Market

    18.1. UK Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Yescarta Market

    19.1. Germany Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Yescarta Market

    20.1. France Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Yescarta Market

    21.1. Eastern Europe Yescarta Market Overview

    21.2. Eastern Europe Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Yescarta Market

    22.1. North America Yescarta Market Overview

    22.2. North America Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Yescarta Market

    23.1. USA Yescarta Market Overview

    23.2. USA Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Yescarta Market

    24.1. Canada Yescarta Market Overview

    24.2. Canada Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Yescarta Market

    25.1. South America Yescarta Market Overview

    25.2. South America Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Yescarta Market

    26.1. Middle East Yescarta Market Overview

    26.2. Middle East Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Yescarta Market

    27.1. Africa Yescarta Market Overview

    27.2. Africa Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Yescarta Market Competitive Landscape And Company Profiles

    28.1. Yescarta Market Competitive Landscape

    28.2. Yescarta Market Company Profiles

    28.2.1. Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.) Overview, Products and Services, Strategy and Financial Analysis

    28.2.2. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.3. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.4. 0 Overview, Products and Services, Strategy and Financial Analysis

    28.2.5. 0 Overview, Products and Services, Strategy and Financial Analysis

    29. Global Yescarta Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Yescarta Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Yescarta Market

    32. Recent Developments In The Yescarta Market

    33. Yescarta Market High Potential Countries, Segments and Strategies

    33.1 Yescarta Market In 2029 - Countries Offering Most New Opportunities

    33.2 Yescarta Market In 2029 - Segments Offering Most New Opportunities

    33.3 Yescarta Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Yescarta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Yescarta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.) Financial Performance
  • Table 60: 0 Financial Performance
  • Table 61: 0 Financial Performance
  • Table 62: 0 Financial Performance
  • Table 63: 0 Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Yescarta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Yescarta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Yescarta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Yescarta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Yescarta Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.) Financial Performance
  • Figure 60: 0 Financial Performance
  • Figure 61: 0 Financial Performance
  • Figure 62: 0 Financial Performance
  • Figure 63: 0 Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the stem cell therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the regenerative medicine for cartilage market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Read More

Chimeric Antigen Receptor T (CAR-T) Cells Global Market Report 2024 – By Target Antigen (CD19, CD22, Other Antigens), By Application (Acute Lymphoblastic Leukaemia, Diffuse Large B-Cell Lymphoma, Other Applications), By End User (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Neoantigen Targeted Therapies Global Market Report 2025 – By Type (Monotherapy, Combination Therapy), By Immunotherapy Type (DNA Or RNA-Based Vaccines, Protein-Based Vaccines, Dendritic Cell Vaccines, TIL-Based Therapies), By Target Disease Indication (Colorectal Cancer, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Bone Cancer, Gynecological Cancer), By Route of Administration (Intradermal, Intravenous, Subcutaneous), By Application (Medical Research Institution, Hospital, and Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Prostate Specific Antigen (PSA) Test Global Market Report 2025 – By Type (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Fluorescence Immunoassay (FIA), Other Types), By Application (Screening, Post-Treatment Monitoring, Other Applications), By End User (Hospitals, Diagnostic Centers, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer biologics Global Market Report 2025 – By Type (Monoclonal Antibodies, Vaccines, Cell And Gene Therapy, Other Types), By Application (Non-small Cell Lung Cancer, Prostate Cancer, Breast Cancer, Acute Myeloid Leukemia, Lymphoma, Multiple Myeloma, Ovarian Cancer, Colorectal Cancer, Gastric Cancers, Other Applications), By Distribution Channel (Hospitals, Clinics, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Skin Cancer Drugs Global Market Report 2025 – By Type (Actinic Keratoses (AK), Basal cell carcinoma (BCC), Squamous cell carcinoma (SCC), Melanoma), By Drug Class (Chemotherapy, Immunotherapy, Targeted Agents & Other Drugs), By End Users (Hospitals, Cancer Research Centers, Clinics) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pancreatic Cancer Drugs Global Market Report 2025 – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Hospital Pharmacies, Retail Pharmacies, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer During Pregnancy, Others)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By End User (Ambulatory, Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)), By End User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Yescarta market?

Yescarta (axicabtagene ciloleucel) is a genetically engineered autologous T-cell therapy used for the treatment of certain types of hematologic cancers, specifically relapsed or refractory large B-cell lymphoma and primary mediastinal B-cell lymphoma in adults. It involves modifying a patient’s own T cells to express a chimeric antigen receptor (CAR) that targets CD19 on cancerous B cells. For further insights on the Yescarta market, request a sample here

How will the Yescarta market drivers and restraints affect the market dynamics? What forces will shape the Yescarta industry going forward?

The Yescarta market major growth driver - Impact Of Rising Leukemia Incidence On The Market Growth. For further insights on the Yescarta market, request a sample here

What is the forecast market size or the forecast market value of the Yescarta market?

The Yescarta market size has grown strongly in recent years. The yescarta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing adoption of immuno-oncology treatments, breakthrough approvals from regulatory agencies, growing prevalence of blood cancers, advancements in gene therapy technologies, increasing healthcare investments in oncology. The yescarta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast expansion into new cancer indications, advancements in manufacturing technologies, increasing healthcare reimbursement for gene therapies, growing patient awareness and demand, strategic partnerships in oncology research. Major trends include the expansion of car T-cell therapies to solid tumors, the development of next-generation car T-cell therapies, increasing focus on personalized cancer treatments, advancements in automation for car T-cell production, growing adoption of combination therapies. For further insights on the Yescarta market, request a sample here

How is the Yescarta market segmented?

The yescarta market covered in this report is segmented –
1) By Indication: Large B-Cell Lymphoma; Mantle Cell Lymphoma; Acute Lymphoblastic Leukemia; Follicular Lymphoma
2) By Distribution Channel: Hospitals; Specialty Clinics; Online Pharmacies
3) By End User: Adult; Geriatric For further insights on the Yescarta market, request a sample here

Which region has the largest share of the Yescarta market? What are the other regions covered in the report?

North America was the largest region in the yescarta market in 2024. The regions covered in the yescarta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Yescarta market, request a sample here.

Who are the major players in the Yescarta market?

Major companies operating in the yescarta market are Kite Pharma Inc. ( a subsidiary of Gilead Sciences Inc.) . For further insights on the Yescarta market, request a sample here.

What are the key trends in the Yescarta market?

Major trends in the Yescarta market include Advancing Oncology With Key Trends And Innovations In The Market. For further insights on the Yescarta market, request a sample here.

What are the major opportunities in the Yescarta market? What are the strategies for the Yescarta market?

For detailed insights on the major opportunities and strategies in the Yescarta market, request a sample here.

How does the Yescarta market relate to the overall economy and other similar markets?

For detailed insights on Yescarta's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Yescarta industry?

For detailed insights on the mergers and acquisitions in the Yescarta industry, request a sample here.

What are the key dynamics influencing the Yescarta market growth? SWOT analysis of the Yescarta market.

For detailed insights on the key dynamics influencing the Yescarta market growth and SWOT analysis of the Yescarta industry, request a sample here.